Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Options
Unusually active option classes on open December 1st » 09:40
12/01/21
12/01
09:40
12/01/21
09:40
ARDX

Ardelyx

$1.16 /

-0.01 (-0.85%)

, ABUS

Arbutus Biopharma

$3.20 /

+ (+0.00%)

, VBIV

VBI Vaccines

$3.04 /

+ (+0.00%)

, VTNR

Vertex Energy

$4.93 /

+ (+0.00%)

, ATNF

180 Life Sciences

$6.37 /

-0.005 (-0.08%)

, XPEV

XPeng

$55.00 /

+ (+0.00%)

, LI

Li Auto

$35.28 /

+ (+0.00%)

, AGC

Altimeter Growth

$12.80 /

+0.05 (+0.39%)

, CCJ

Cameco

$23.19 /

+ (+0.00%)

, MRK

Merck

$74.87 /

+0.01 (+0.01%)

Unusual total active…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARDX Ardelyx
$1.16 /

-0.01 (-0.85%)

ABUS Arbutus Biopharma
$3.20 /

+ (+0.00%)

VBIV VBI Vaccines
$3.04 /

+ (+0.00%)

VTNR Vertex Energy
$4.93 /

+ (+0.00%)

ATNF 180 Life Sciences
$6.37 /

-0.005 (-0.08%)

XPEV XPeng
$55.00 /

+ (+0.00%)

LI Li Auto
$35.28 /

+ (+0.00%)

AGC Altimeter Growth
$12.80 /

+0.05 (+0.39%)

CCJ Cameco
$23.19 /

+ (+0.00%)

MRK Merck
$74.87 /

+0.01 (+0.01%)

ARDX Ardelyx
$1.16 /

-0.01 (-0.85%)

06:44 Today Ladenburg
Ardelyx upgraded to Buy at Ladenburg on IBS-C treatment launch plan
06:32 Today Ladenburg
Ardelyx upgraded to Buy from Neutral at Ladenburg
06:28 Today Citi
Ardelyx price target raised to $13 from $7 at Citi
11/30/21 Citi
Ardelyx price target raised to $13 from $7 at Citi
ABUS Arbutus Biopharma
$3.20 /

+ (+0.00%)

11/08/21 H.C. Wainwright
Arbutus Biopharma price target lowered to $8 from $10 at H.C. Wainwright
06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley Securities
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
VBIV VBI Vaccines
$3.04 /

+ (+0.00%)

02/25/21 Jefferies
VBI Vaccines initiated with a Buy at Jefferies
VTNR Vertex Energy
$4.93 /

+ (+0.00%)

07:01 Today Credit Suisse
Vertex Energy initiated with an Outperform at Credit Suisse
11/09/21 Craig-Hallum
Vertex Energy price target lowered to $18 from $25 at Craig-Hallum
06/30/21 Craig-Hallum
Vertex Energy price target raised to $25 from $13 at Craig-Hallum
06/01/21 Stifel
Vertex Energy price target raised to $17 from $2 at Stifel
ATNF 180 Life Sciences
$6.37 /

-0.005 (-0.08%)

09/15/21 Maxim
180 Life Sciences initiated with a Buy at Maxim
09/15/21 Maxim
180 Life Sciences initiated with a Buy at Maxim
XPEV XPeng
$55.00 /

+ (+0.00%)

11/24/21 BofA
XPeng price target raised to $66 from $63 at BofA
11/24/21 Citi
XPeng price target raised to $92 from $87 at Citi
11/11/21 Citi
XPeng price target raised to $87 from $53.40 at Citi
10/28/21
Fly Intel: Top five analyst initiations
LI Li Auto
$35.28 /

+ (+0.00%)

11/11/21 Citi
Li Auto price target raised to $200 from $165 at Citi
10/28/21
Fly Intel: Top five analyst initiations
10/28/21 Bernstein
Bernstein starts Li Auto at Outperform, sees EVs as 'future' of Chinese autos
10/28/21 Bernstein
Li Auto initiated with an Outperform at Bernstein
AGC Altimeter Growth
$12.80 /

+0.05 (+0.39%)

10/01/21 New Street
Grab partner Altimeter Growth initiated with a Buy at New Street
CCJ Cameco
$23.19 /

+ (+0.00%)

11/03/21 BofA
Cameco upgraded to Buy from Neutral at BofA
11/03/21 BofA
Cameco upgraded to Buy from Neutral at BofA
11/02/21 BMO Capital
Cameco price target raised to C$28 from C$26 at BMO Capital
11/01/21 RBC Capital
Cameco price target raised to C$29 from C$26 at RBC Capital
MRK Merck
$74.87 /

+0.01 (+0.01%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
ARDX Ardelyx
$1.16 /

-0.01 (-0.85%)

ABUS Arbutus Biopharma
$3.20 /

+ (+0.00%)

VBIV VBI Vaccines
$3.04 /

+ (+0.00%)

VTNR Vertex Energy
$4.93 /

+ (+0.00%)

XPEV XPeng
$55.00 /

+ (+0.00%)

LI Li Auto
$35.28 /

+ (+0.00%)

CCJ Cameco
$23.19 /

+ (+0.00%)

MRK Merck
$74.87 /

+0.01 (+0.01%)

  • 13
    Aug
  • 09
    Dec
  • 04
    Dec
XPEV XPeng
$55.00 /

+ (+0.00%)

LI Li Auto
$35.28 /

+ (+0.00%)

AGC Altimeter Growth
$12.80 /

+0.05 (+0.39%)

MRK Merck
$74.87 /

+0.01 (+0.01%)

ARDX Ardelyx
$1.16 /

-0.01 (-0.85%)

ABUS Arbutus Biopharma
$3.20 /

+ (+0.00%)

VTNR Vertex Energy
$4.93 /

+ (+0.00%)

XPEV XPeng
$55.00 /

+ (+0.00%)

LI Li Auto
$35.28 /

+ (+0.00%)

AGC Altimeter Growth
$12.80 /

+0.05 (+0.39%)

MRK Merck
$74.87 /

+0.01 (+0.01%)

ARDX Ardelyx
$1.16 /

-0.01 (-0.85%)

ABUS Arbutus Biopharma
$3.20 /

+ (+0.00%)

VTNR Vertex Energy
$4.93 /

+ (+0.00%)

ATNF 180 Life Sciences
$6.37 /

-0.005 (-0.08%)

XPEV XPeng
$55.00 /

+ (+0.00%)

LI Li Auto
$35.28 /

+ (+0.00%)

AGC Altimeter Growth
$12.80 /

+0.05 (+0.39%)

CCJ Cameco
$23.19 /

+ (+0.00%)

MRK Merck
$74.87 /

+0.01 (+0.01%)

Hot Stocks
Nielsen, AccuWeather Network enter multi-year TV agreement » 08:31
12/01/21
12/01
08:31
12/01/21
08:31
NLSN

Nielsen

$19.17 /

-1.01 (-5.00%)

The AccuWeather Network…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NLSN Nielsen
$19.17 /

-1.01 (-5.00%)

NLSN Nielsen
$19.17 /

-1.01 (-5.00%)

09/10/21 Citi
Nielsen price target lowered to $21 from $28 at Citi
08/25/21 Craig-Hallum
Comscore accreditation audit process accelerated, says Craig-Hallum
07/07/21 RBC Capital
Nielsen initiated with a Sector Perform at RBC Capital
06/28/21 Craig-Hallum
Craig-Hallum bullish on Comscore, initiates with a Buy
NLSN Nielsen
$19.17 /

-1.01 (-5.00%)

NLSN Nielsen
$19.17 /

-1.01 (-5.00%)

NLSN Nielsen
$19.17 /

-1.01 (-5.00%)

NLSN Nielsen
$19.17 /

-1.01 (-5.00%)

Hot Stocks
Merck: FDA accepts for priority review sBLA for VAXNEUVANCE » 06:50
12/01/21
12/01
06:50
12/01/21
06:50
MRK

Merck

$74.87 /

-0.005 (-0.01%)

Merck announced the U.S.…

Merck announced the U.S. FDA has accepted for Priority Review a supplemental Biologics License Application for VAXNEUVANCE for the prevention of invasive pneumococcal disease in children 6 weeks through 17 years of age. The FDA grants priority review to medicines and vaccines that, if approved, would provide a significant improvement in the safety or effectiveness of the treatment or prevention of a serious condition. The FDA set a Prescription Drug User Fee Act, or target action date, of April 1, 2022.

ShowHide Related Items >><<
MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

Yesterday
On The Fly
Fly Intel: After-Hours Movers » 18:28
11/30/21
11/30
18:28
11/30/21
18:28
AMBA

Ambarella

$180.08 /

-1.835 (-1.01%)

, BOX

Box

$23.47 /

-0.73 (-3.02%)

, ZS

Zscaler

$347.02 /

-8.795 (-2.47%)

, NTAP

NetApp

$89.00 /

-2.545 (-2.78%)

, GFS

GlobalFoundries

$69.42 /

-1.05 (-1.49%)

, BBW

Build-A-Bear

$17.01 /

-0.02 (-0.12%)

, MNTS

Momentus

$6.87 /

-0.27 (-3.78%)

, MRK

Merck

$74.87 /

-0.005 (-0.01%)

, LSTR

Landstar System

$168.60 /

-4.02 (-2.33%)

, MA

MasterCard

$314.80 /

-8.18 (-2.53%)

, EMKR

Emcore

$7.40 /

-0.14 (-1.86%)

, CRM

Salesforce

$285.03 /

-11.56 (-3.90%)

, BIRD

Allbirds

$19.33 /

+0.5 (+2.66%)

, HPE

HP Enterprise

$14.38 /

-0.22 (-1.51%)

, LAC

Lithium Americas

$39.33 /

-1.64 (-4.00%)

, IMGN

ImmunoGen

$6.18 /

+1.42 (+29.83%)

Check out this evening's…

ShowHide Related Items >><<
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

NTAP NetApp
$89.00 /

-2.545 (-2.78%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MNTS Momentus
$6.87 /

-0.27 (-3.78%)

MA MasterCard
$314.80 /

-8.18 (-2.53%)

LAC Lithium Americas
$39.33 /

-1.64 (-4.00%)

IMGN ImmunoGen
$6.18 /

+1.42 (+29.83%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

EMKR Emcore
$7.40 /

-0.14 (-1.86%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

BOX Box
$23.47 /

-0.73 (-3.02%)

BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

11/29/21 Morgan Stanley
Ambarella price target raised to $222 from $137 at Morgan Stanley
10/27/21 Needham
Ambarella price target raised to $220 from $140 at Needham
10/27/21 Roth Capital
Ambarella price target raised to $225 from $170 at Roth Capital
10/27/21 Stifel
Ambarella price target raised to $200 after Oculii deal at Stifel
BOX Box
$23.47 /

-0.73 (-3.02%)

10/07/21
Fly Intel: Top five analyst downgrades
10/07/21 Morgan Stanley
Morgan Stanley downgrades Box on resumption after stock outperformance
10/07/21 Morgan Stanley
Box downgraded to Equal Weight from Overweight at Morgan Stanley
09/27/21
Fly Intel: Top five analyst upgrades
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

11/29/21 Needham
Zscaler price target raised to $390 from $345 at Needham
11/29/21 RBC Capital
Zscaler price target raised to $380 from $326 at RBC Capital
11/24/21 Deutsche Bank
Zscaler price target raised to $400 from $325 at Deutsche Bank
11/16/21 Credit Suisse
Zscaler initiated with an Outperform at Credit Suisse
NTAP NetApp
$89.00 /

-2.545 (-2.78%)

11/24/21 Morgan Stanley
Dell Technologies price target raised to $68 from $67 at Morgan Stanley
10/18/21 Goldman Sachs
NetApp downgraded to Sell from Neutral at Goldman Sachs
10/14/21 Citi
NetApp upgraded to Buy from Sell at Citi
09/29/21 JPMorgan
NetApp price target raised to $108 from $95 at JPMorgan
GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

11/22/21
Fly Intel: Top five analyst initiations
11/22/21 HSBC
GlobalFoundries initiated with a Hold at HSBC
11/22/21 BofA
BofA starts GlobalFoundries at Buy, sees 40% upside potential
11/22/21 JPMorgan
GlobalFoundries initiated with an Overweight at JPMorgan
BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

MNTS Momentus
$6.87 /

-0.27 (-3.78%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
LSTR Landstar System
$168.60 /

-4.02 (-2.33%)

10/22/21 Truist
Landstar System price target raised to $165 from $155 at Truist
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 Evercore ISI
Landstar System initiated with an In Line at Evercore ISI
09/13/21 Evercore ISI
Landstar System initiated with an In Line at Evercore ISI
MA MasterCard
$314.80 /

-8.18 (-2.53%)

11/17/21 UBS
UBS assumes coverage of MasterCard with a Buy, citing increasing travel demand
11/17/21 UBS
MasterCard assumed with a Buy at UBS
11/17/21 Cowen
Amazon to stop accepting Visa cards in UK, says Cowen
11/15/21 Mizuho
MasterCard price target raised to $465 from $450 at Mizuho
EMKR Emcore
$7.40 /

-0.14 (-1.86%)

08/05/21 Lake Street
Emcore price target raised to $13 from $8 at Lake Street
05/26/21 Cowen
Cowen starts Emcore at Outperform, sees attractive risk/reward
05/26/21 Cowen
Emcore initiated with an Outperform at Cowen
03/04/21
Fly Intel: Top five analyst initiations
CRM Salesforce
$285.03 /

-11.56 (-3.90%)

11/23/21 BofA
Salesforce price target raised to $360 from $330 at BofA
11/23/21 Jefferies
Salesforce price target raised to $360 from $325 at Jefferies
11/23/21 Citi
Salesforce price target raised to $308 from $280 at Citi
11/22/21 Atlantic Equities
Atlantic Equities assumes 'low-risk' Salesforce at Overweight
BIRD Allbirds
$19.33 /

+0.5 (+2.66%)

11/29/21
Fly Intel: Top five analyst initiations
11/29/21 Guggenheim
Guggenheim starts Allbirds at Buy, sees 50% potential upside
11/29/21 Guggenheim
Allbirds initiated with a Buy at Guggenheim
11/29/21 JPMorgan
Allbirds initiated with a Neutral at JPMorgan
HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

11/11/21 Goldman Sachs
HP Enterprise downgraded to Sell from Neutral at Goldman Sachs
10/06/21 Morgan Stanley
HP Enterprise price target lowered to $16 from $18 at Morgan Stanley
09/03/21 Raymond James
HP Enterprise price target raised to $22 from $20 at Raymond James
09/03/21 Wells Fargo
HP Enterprise price target raised to $20 from $18 at Wells Fargo
LAC Lithium Americas
$39.33 /

-1.64 (-4.00%)

11/24/21 B. Riley
Lithium Americas price target raised to $44 from $25 at B. Riley
11/22/21 Piper Sandler
Lithium Americas price target raised to $32 from $22 at Piper Sandler
11/19/21 JPMorgan
Lithium Americas price target raised to $39 from $28 at JPMorgan
11/18/21 Canaccord
Lithium Americas price target raised to C$46 from C$35 at Canaccord
IMGN ImmunoGen
$6.18 /

+1.42 (+29.83%)

11/30/21 Piper Sandler
Piper says outlook on ImmunoGen's mirve opportunity 'largely unchanged'
11/30/21 RBC Capital
ImmunoGen price target raised to $9 from $8 at RBC Capital
06/07/21 Piper Sandler
ImmunoGen data largely consistent with prior updates, says Piper Sandler
05/10/21 Piper Sandler
Piper says ImmunoGen's 'modest' timeline slip makes cash runway 'more tenuous'
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

NTAP NetApp
$89.00 /

-2.545 (-2.78%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MA MasterCard
$314.80 /

-8.18 (-2.53%)

LSTR Landstar System
$168.60 /

-4.02 (-2.33%)

LAC Lithium Americas
$39.33 /

-1.64 (-4.00%)

IMGN ImmunoGen
$6.18 /

+1.42 (+29.83%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

EMKR Emcore
$7.40 /

-0.14 (-1.86%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

BOX Box
$23.47 /

-0.73 (-3.02%)

BIRD Allbirds
$19.33 /

+0.5 (+2.66%)

BBW Build-A-Bear
$17.01 /

-0.02 (-0.12%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

  • 02
    Dec
  • 03
    Nov
  • 28
    Oct
  • 11
    Feb
  • 20
    Jan
ZS Zscaler
$347.02 /

-8.795 (-2.47%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MA MasterCard
$314.80 /

-8.18 (-2.53%)

LAC Lithium Americas
$39.33 /

-1.64 (-4.00%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

BOX Box
$23.47 /

-0.73 (-3.02%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

NTAP NetApp
$89.00 /

-2.545 (-2.78%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MA MasterCard
$314.80 /

-8.18 (-2.53%)

LAC Lithium Americas
$39.33 /

-1.64 (-4.00%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

BOX Box
$23.47 /

-0.73 (-3.02%)

BIRD Allbirds
$19.33 /

+0.5 (+2.66%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

ZS Zscaler
$347.02 /

-8.795 (-2.47%)

NTAP NetApp
$89.00 /

-2.545 (-2.78%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MNTS Momentus
$6.87 /

-0.27 (-3.78%)

MA MasterCard
$314.80 /

-8.18 (-2.53%)

LAC Lithium Americas
$39.33 /

-1.64 (-4.00%)

HPE HP Enterprise
$14.38 /

-0.22 (-1.51%)

GFS GlobalFoundries
$69.42 /

-1.05 (-1.49%)

CRM Salesforce
$285.03 /

-11.56 (-3.90%)

BOX Box
$23.47 /

-0.73 (-3.02%)

BIRD Allbirds
$19.33 /

+0.5 (+2.66%)

AMBA Ambarella
$180.08 /

-1.835 (-1.01%)

Hot Stocks
Merck says FDA panel vote on COVID antiviral a 'positive outcome' » 17:53
11/30/21
11/30
17:53
11/30/21
17:53
MRK

Merck

$74.87 /

-0.005 (-0.01%)

Merck and Ridgeback…

Merck and Ridgeback Biotherapeutics provided a statement at the conclusion of the U.S. Food and Drug Administration's Antimicrobial Drugs Advisory Committee regarding the Emergency Use Authorization application for molnupiravir, an investigational oral antiviral medicine, for the treatment of mild to moderate COVID-19 in adults with positive results of direct SARS-CoV-2 viral testing who are at high risk for progressing to severe COVID-19 and/or hospitalization. The Advisory Committee voted 13-10 that the known and potential benefits of molnupiravir outweigh its known and potential risks for the treatment of mild to moderate COVID-19 in high risk adult patients who are within five days of symptom onset. The FDA is not bound by the committee's guidance but takes its advice into consideration. "The positive outcome of today's FDA Advisory Committee meeting, following a comprehensive review of molnupiravir, including the compelling data from the MOVe-OUT study demonstrating a significant reduction in hospitalizations and deaths, is a critical step toward bringing this promising oral medicine for COVID-19 to appropriate patients in the U.S. With the continued spread of the virus and the emergence of variants, additional treatments for COVID-19 are urgently needed. That is why we are moving with speed and rigor to pursue authorizations and to accelerate broad global access to this investigational medicine," said Dr. Dean Y. Li, executive vice president and president, Merck Research Laboratories. "We are grateful to the members of the Advisory Committee who reviewed our application, as well as to the patients and investigators who participated in our clinical trials, and we will continue to work with the FDA as the agency completes its review."

ShowHide Related Items >><<
MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

Periodicals
FDA panel votes 13-10 in support of Merck COVID pill, CNBC reports » 17:00
11/30/21
11/30
17:00
11/30/21
17:00
MRK

Merck

$74.87 /

-0.005 (-0.01%)

The FDA's…

The FDA's Antimicrobial Drugs Advisory Committee narrowly endorse the use of Merck and Rideback's oral COVID-19 treatment, despite questions about the pill's efficacy, safety, and whether it would help the virus mutate into more potentially harmful variants, CNBC's Spencer Kimball reports. The panel voted 13-10 in favor of recommending emergency authorization of oral antiviral molnupiravir, which was initially hailed as a possible game changer in the fight against COVID, the author notes. The treatment needs final approval from the FDA and CDC before it's available to the public, the author says. Reference Link

ShowHide Related Items >><<
MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

Periodicals
FDA AdCom votes 13-10 in support of Merck COVID pill, Bloomberg reports  16:53
11/30/21
11/30
16:53
11/30/21
16:53
MRK

Merck

$74.87 /

-0.005 (-0.01%)

 
ShowHide Related Items >><<
MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

On The Fly
Wall Street in Fives - Must Read Lists for Tuesday » 16:22
11/30/21
11/30
16:22
11/30/21
16:22
REGN

Regeneron

$636.37 /

-17.98 (-2.75%)

, FB

Facebook; also tag MVRS

$324.30 /

-13.525 (-4.00%)

, MVRS

Meta

/

+

, SHOP

Shopify

$1,520.40 /

-48.74 (-3.11%)

, AMZN

Amazon.com

$3,507.58 /

-54.42 (-1.53%)

, $ECON

Economic Data

/

+

, SPY

SPDR S&P 500 ETF Trust

$455.84 /

-8.8 (-1.89%)

, SPX

S&P 500

/

+

, SQ

Square

$208.53 /

-4.46 (-2.09%)

, BYND

Beyond Meat

$70.33 /

-4.23 (-5.67%)

, RKLB

Rocket Lab

$15.90 /

+0.445 (+2.88%)

, DLTR

Dollar Tree

$133.57 /

-7.89 (-5.58%)

, VIR

Vir Biotechnology

$47.39 /

+6.87 (+16.95%)

, LULU

Lululemon

$454.65 /

-9.6 (-2.07%)

, MRNA

Moderna

$353.10 /

-15.085 (-4.10%)

, MRK

Merck

$74.87 /

-0.005 (-0.01%)

, BIIB

Biogen

$235.67 /

-0.68 (-0.29%)

, ZEN

Zendesk

$102.07 /

+6.955 (+7.31%)

, MNTV

Momentive

$20.46 /

-0.67 (-3.17%)

, MEIP

MEI Pharma

$3.44 /

+0.98 (+39.84%)

, IBRX

ImmunityBio

$7.77 /

+1.36 (+21.22%)

, RDHL

RedHill Biopharma

$2.91 /

+0.11 (+3.93%)

, OLMA

Olema Oncology

$8.77 /

-13.19 (-60.06%)

, VIAC

ViacomCBS

$30.93 /

-1.35 (-4.18%)

, VIACA

ViacomCBS

$33.38 /

-1.5 (-4.30%)

, CTRN

Citi Trends

$84.72 /

+6.7 (+8.59%)

, CHS

Chico's

$5.75 /

+0.21 (+3.79%)

, JKS

JinkoSolar

$52.32 /

-3.6 (-6.44%)

, BZUN

Baozun

$13.73 /

-1.1 (-7.42%)

, BNED

Barnes & Noble Education

$7.03 /

-1.865 (-20.97%)

Get caught up quickly on…

ShowHide Related Items >><<
ZEN Zendesk
$102.07 /

+6.955 (+7.31%)

VIR Vir Biotechnology
$47.39 /

+6.87 (+16.95%)

VIAC ViacomCBS
$30.93 /

-1.35 (-4.18%)

SQ Square
$208.53 /

-4.46 (-2.09%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SPX S&P 500
/

+

SHOP Shopify
$1,520.40 /

-48.74 (-3.11%)

RKLB Rocket Lab
$15.90 /

+0.445 (+2.88%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

RDHL RedHill Biopharma
$2.91 /

+0.11 (+3.93%)

OLMA Olema Oncology
$8.77 /

-13.19 (-60.06%)

MRNA Moderna
$353.10 /

-15.085 (-4.10%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MNTV Momentive
$20.46 /

-0.67 (-3.17%)

MEIP MEI Pharma
$3.44 /

+0.98 (+39.84%)

LULU Lululemon
$454.65 /

-9.6 (-2.07%)

JKS JinkoSolar
$52.32 /

-3.6 (-6.44%)

IBRX ImmunityBio
$7.77 /

+1.36 (+21.22%)

FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

DLTR Dollar Tree
$133.57 /

-7.89 (-5.58%)

CTRN Citi Trends
$84.72 /

+6.7 (+8.59%)

CHS Chico's
$5.75 /

+0.21 (+3.79%)

BZUN Baozun
$13.73 /

-1.1 (-7.42%)

BYND Beyond Meat
$70.33 /

-4.23 (-5.67%)

BNED Barnes & Noble Education
$7.03 /

-1.865 (-20.97%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

AMZN Amazon.com
$3,507.58 /

-54.42 (-1.53%)

$ECON Economic Data
/

+

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

11/30/21 H.C. Wainwright
Regeneron should be bought on today's selloff, says H.C. Wainwright
11/29/21 Morgan Stanley
Morgan Stanley, assuming Omicron becomes dominant, ups Adagio to Overweight
11/18/21 BMO Capital
Regeneron assumed with an Outperform at BMO Capital
11/10/21 Cantor Fitzgerald
Regeneron price target raised to $760 from $700 at Cantor Fitzgerald
FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

11/19/21 JMP Securities
DoubleVerify may see $200M opportunity from Facebook news, says JMP Securities
11/17/21 Goldman Sachs
Amazon named top Americas Internet pick for 2022 at Goldman Sachs
11/09/21 Morgan Stanley
Twitter price target lowered to $62 from $68 at Morgan Stanley
11/09/21 Susquehanna
AMD price target raised to $175 from $145 at Susquehanna
MVRS Meta
/

+

11/08/21 Stifel
AMD-Meta partnership shows secular growth thesis 'gaining momentum,' says Stifel
10/28/21 Piper Sandler
Facebook name change a 'big, bold and risky bet,' says Piper Sandler
SHOP Shopify
$1,520.40 /

-48.74 (-3.11%)

11/24/21 Jefferies
Global-e deal for Flow Commerce strengthens D2C position, says Jefferies
11/15/21
Fly Intel: Top five analyst downgrades
11/15/21 Loop Capital
Shopify downgraded to Hold at Loop Capital on valuation
11/15/21 Loop Capital
Shopify downgraded to Hold from Buy at Loop Capital
AMZN Amazon.com
$3,507.58 /

-54.42 (-1.53%)

11/24/21 JPMorgan
Amazon should surpass Walmart as largest retailer in 2022, says JPMorgan
11/22/21 Guggenheim
Amazon.com assumed with a Buy at Guggenheim
11/19/21 RBC Capital
Williams-Sonoma price target raised to $219 from $199 at RBC Capital
11/18/21 Bernstein
Amazon card news in the U.K. 'clearly a show of strength,' says Bernstein
$ECON Economic Data
/

+

11/22/21 BTIG
In picking Powell, Biden went with 'safest choice,' says BTIG
08/04/21 Citi
Citi sees 10-year yield rising to 2%, cuts 'tech-heavy' U.S. to Neutral
SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

11/26/21 Morgan Stanley
Covid variant mutations may reduce vaccine effectiveness, says Morgan Stanley
11/26/21 Credit Suisse
Concerns over new Covid variant 'understandable,' says Credit Suisse
SPX S&P 500
/

+

SQ Square
$208.53 /

-4.46 (-2.09%)

11/30/21
Fly Intel: Top five analyst upgrades
11/30/21 BofA
Square upgraded to Neutral from Underperform at BofA
11/30/21 BofA
Square upgraded to Neutral from Underperform at BofA
11/17/21 UBS
Square initiated with a Buy at UBS
BYND Beyond Meat
$70.33 /

-4.23 (-5.67%)

11/30/21
Fly Intel: Top five analyst initiations
11/30/21 HSBC
HSBC starts Beyond Meat with sell on 'increasingly competitive' market
11/29/21 HSBC
Beyond Meat initiated with a Reduce at HSBC
11/15/21 Cowen
Beyond Meat price target lowered to $79 from $101 at Cowen
RKLB Rocket Lab
$15.90 /

+0.445 (+2.88%)

11/30/21 BofA
Rocket Lab initiated with a Buy at BofA
11/30/21 BofA
Rocket Lab initiated with a Buy at BofA
10/04/21 BofA
Astra initiated with an Underperform at BofA
09/30/21 Stifel
Rocket Lab initiated with a Buy at Stifel
DLTR Dollar Tree
$133.57 /

-7.89 (-5.58%)

11/30/21
Fly Intel: Top five analyst downgrades
11/29/21 Goldman Sachs
Goldman Sachs downgrades Dollar Tree to Neutral, ups price target to $150
11/29/21 Goldman Sachs
Dollar Tree downgraded to Neutral from Buy at Goldman Sachs
11/26/21 Morgan Stanley
Dollar Tree 'bull case path' to over $200 'getting clearer,' says Morgan Stanley
VIR Vir Biotechnology
$47.39 /

+6.87 (+16.95%)

11/30/21 H.C. Wainwright
Vir Biotechnology price target raised to $200 from $135 at H.C. Wainwright
11/17/21 Baird
Baird ups Vir Biotechnology target to $36 on new U.S. contract for Sotrovimab
10/25/21
Fly Intel: Top five analyst upgrades
10/25/21 JPMorgan
JPMorgan upgrades Vir to Neutral on estimate upside potential
LULU Lululemon
$454.65 /

-9.6 (-2.07%)

08:24 Today Argus
Lululemon price target raised to $530 from $500 at Argus
11/18/21 Cowen
Cowen lays out top retail picks into strongest holiday in 20 years
11/17/21 B. Riley
Lululemon price target raised to $548 from $466 at B. Riley
10/29/21 JPMorgan
Lululemon price target raised to $570 from $500 at JPMorgan
MRNA Moderna
$353.10 /

-15.085 (-4.10%)

11/28/21 Piper Sandler
Moderna has multiple booster candidates to combat omicron, says Piper Sandler
11/26/21 Piper Sandler
Moderna has been preparing for emergence of new variants, says Piper Sandler
11/23/21 Morgan Stanley
Positive flu vaccine data can drive Moderna 10%-20% higher, says Morgan Stanley
11/19/21 Piper Sandler
Moderna can gain share from Pfizer in booster market, says Piper Sandler
MRK Merck
$74.87 /

-0.005 (-0.01%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
BIIB Biogen
$235.67 /

-0.68 (-0.29%)

11/30/21 Wedbush
Wedbush keeps Neutral rating on Biogen after court denies appeal in patent case
11/18/21 BMO Capital
Biogen initiated with an Outperform at BMO Capital
11/17/21 Cowen
Cowen says Biogen negative vote at CHMP 'disappointing, but far from surprising'
11/17/21 Stifel
Biogen shares weren't really pricing in Europe approval, says Stifel
ZEN Zendesk
$102.07 /

+6.955 (+7.31%)

11/30/21 Craig-Hallum
Zendesk price target lowered to $140 from $150 at Craig-Hallum
11/19/21
Fly Intel: Top five analyst downgrades
11/19/21 Stifel
Zendesk's upcoming deal proxy may help investors gain comfort, says Stifel
11/19/21 Cowen
Zendesk downgraded to Market Perform from Outperform at Cowen
MNTV Momentive
$20.46 /

-0.67 (-3.17%)

11/18/21 Jefferies
Zendesk price target lowered to $110 from $120 at Jefferies
11/16/21 Credit Suisse
Zendesk initiated with a Neutral at Credit Suisse
MEIP MEI Pharma
$3.44 /

+0.98 (+39.84%)

09/09/21 Truist
MEI Pharma price target lowered to $8 from $12 at Truist
09/07/21 Brookline
MEI Pharma price target raised to $20 from $11.50 at Brookline
04/26/21 Wells Fargo
MEI Pharma likely to expand scope of voruciclib development, says Wells Fargo
IBRX ImmunityBio
$7.77 /

+1.36 (+21.22%)

10/19/21 Piper Sandler
Piper says ImmunityBio could have 'blockbuster opportunity' with Anktiva
06/04/21 Piper Sandler
ImmunityBio shared 'positive data points' on N-803 at ASCO, says Piper Sandler
04/07/21 Piper Sandler
ImmunityBio price target raised to $25 from $18 at Piper Sandler
RDHL RedHill Biopharma
$2.91 /

+0.11 (+3.93%)

08:18 Today BTIG
RedHill Biopharma price target lowered to $10 from $16 at BTIG
11/18/21
RedHill Biopharma files to sell common stock, no amount given
09/15/21 BTIG
RedHill Biopharma price target lowered to $16 from $24 at BTIG
09/15/21 H.C. Wainwright
RedHill Biopharma price target lowered to $21 from $23 at H.C. Wainwright
OLMA Olema Oncology
$8.77 /

-13.19 (-60.06%)

10/11/21
Olema Oncology participates in a conference call with JPMorgan
05/25/21 JPMorgan
Olema selloff brings 'compelling' entry point, says JPMorgan
12/14/20 JPMorgan
Olema Oncology initiated with an Overweight at JPMorgan
12/14/20 Jefferies
Olema Pharmaceuticals initiated with a Buy at Jefferies
VIAC ViacomCBS
$30.93 /

-1.35 (-4.18%)

10/15/21 Deutsche Bank
ViacomCBS price target lowered to $44 from $45 at Deutsche Bank
08/18/21
Fly Intel: Top five analyst upgrades
08/18/21 Wells Fargo
ViacomCBS upgraded to Overweight from Equal Weight at Wells Fargo
08/06/21
Fly Intel: Top five analyst upgrades
VIACA ViacomCBS
$33.38 /

-1.5 (-4.30%)

01/05/21 Gabelli
ViacomCBS named a best idea for 2021 at Gabelli
CTRN Citi Trends
$84.72 /

+6.7 (+8.59%)

10/28/21
Citi Trends management to meet with Benchmark
09/21/21 Benchmark
Citi Trends initiated with a Buy at Benchmark
08/25/21 Craig-Hallum
Citi Trends price target raised to $165 from $150 at Craig-Hallum
05/26/21 Craig-Hallum
Citi Trends price target raised to $150 from $142 at Craig-Hallum
CHS Chico's
$5.75 /

+0.21 (+3.79%)

06/09/21 B. Riley
Chico's price target raised to $5.25 from $2.50 at B. Riley
03/03/21 B. Riley
Chico's price target raised to $2.50 from $2 at B. Riley Securities
01/15/21 B. Riley
Chico's price target raised to $2 from $1.50 at B. Riley Securities
JKS JinkoSolar
$52.32 /

-3.6 (-6.44%)

11/22/21 GLJ Research
U.S. to imminently appeal bi-facial solar panel decision, says GLJ Research
11/16/21 Roth Capital
Roth says court restoring solar 'bifi' exemption a 'major surprise'
11/15/21 Roth Capital
Roth Capital not expecting A-SMACC to reveal petitioner to keep anti-circ case alive
11/10/21 Roth Capital
Anti-Circ thrown out, incremental negative for First Solar, says Roth Capital
BZUN Baozun
$13.73 /

-1.1 (-7.42%)

06:20 Today Citi
Baozun price target lowered to $19 from $22 at Citi
10/20/21 Citi
Baozun price target lowered to $22 from $34 at Citi
08/20/21 Daiwa
Baozun downgraded to Neutral from Buy at Daiwa
08/20/21 HSBC
Baozun price target lowered to $22 from $38 at HSBC
BNED Barnes & Noble Education
$7.03 /

-1.865 (-20.97%)

ZEN Zendesk
$102.07 /

+6.955 (+7.31%)

VIR Vir Biotechnology
$47.39 /

+6.87 (+16.95%)

VIAC ViacomCBS
$30.93 /

-1.35 (-4.18%)

SQ Square
$208.53 /

-4.46 (-2.09%)

SHOP Shopify
$1,520.40 /

-48.74 (-3.11%)

RKLB Rocket Lab
$15.90 /

+0.445 (+2.88%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

RDHL RedHill Biopharma
$2.91 /

+0.11 (+3.93%)

MRNA Moderna
$353.10 /

-15.085 (-4.10%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MNTV Momentive
$20.46 /

-0.67 (-3.17%)

MEIP MEI Pharma
$3.44 /

+0.98 (+39.84%)

LULU Lululemon
$454.65 /

-9.6 (-2.07%)

JKS JinkoSolar
$52.32 /

-3.6 (-6.44%)

IBRX ImmunityBio
$7.77 /

+1.36 (+21.22%)

FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

DLTR Dollar Tree
$133.57 /

-7.89 (-5.58%)

CTRN Citi Trends
$84.72 /

+6.7 (+8.59%)

CHS Chico's
$5.75 /

+0.21 (+3.79%)

BZUN Baozun
$13.73 /

-1.1 (-7.42%)

BYND Beyond Meat
$70.33 /

-4.23 (-5.67%)

BNED Barnes & Noble Education
$7.03 /

-1.865 (-20.97%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

AMZN Amazon.com
$3,507.58 /

-54.42 (-1.53%)

  • 19
    Nov
  • 06
    Apr
  • 29
    Mar
  • 24
    Mar
  • 02
    Mar
  • 23
    Feb
ZEN Zendesk
$102.07 /

+6.955 (+7.31%)

VIR Vir Biotechnology
$47.39 /

+6.87 (+16.95%)

VIAC ViacomCBS
$30.93 /

-1.35 (-4.18%)

SQ Square
$208.53 /

-4.46 (-2.09%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SHOP Shopify
$1,520.40 /

-48.74 (-3.11%)

RKLB Rocket Lab
$15.90 /

+0.445 (+2.88%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

MVRS Meta
/

+

MRNA Moderna
$353.10 /

-15.085 (-4.10%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

MNTV Momentive
$20.46 /

-0.67 (-3.17%)

LULU Lululemon
$454.65 /

-9.6 (-2.07%)

FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

DLTR Dollar Tree
$133.57 /

-7.89 (-5.58%)

BYND Beyond Meat
$70.33 /

-4.23 (-5.67%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

AMZN Amazon.com
$3,507.58 /

-54.42 (-1.53%)

$ECON Economic Data
/

+

ZEN Zendesk
$102.07 /

+6.955 (+7.31%)

VIR Vir Biotechnology
$47.39 /

+6.87 (+16.95%)

VIAC ViacomCBS
$30.93 /

-1.35 (-4.18%)

SQ Square
$208.53 /

-4.46 (-2.09%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SHOP Shopify
$1,520.40 /

-48.74 (-3.11%)

RKLB Rocket Lab
$15.90 /

+0.445 (+2.88%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

MNTV Momentive
$20.46 /

-0.67 (-3.17%)

LULU Lululemon
$454.65 /

-9.6 (-2.07%)

JKS JinkoSolar
$52.32 /

-3.6 (-6.44%)

FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

DLTR Dollar Tree
$133.57 /

-7.89 (-5.58%)

CHS Chico's
$5.75 /

+0.21 (+3.79%)

BYND Beyond Meat
$70.33 /

-4.23 (-5.67%)

BNED Barnes & Noble Education
$7.03 /

-1.865 (-20.97%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

AMZN Amazon.com
$3,507.58 /

-54.42 (-1.53%)

$ECON Economic Data
/

+

VIAC ViacomCBS
$30.93 /

-1.35 (-4.18%)

SQ Square
$208.53 /

-4.46 (-2.09%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SPX S&P 500
/

+

SHOP Shopify
$1,520.40 /

-48.74 (-3.11%)

RKLB Rocket Lab
$15.90 /

+0.445 (+2.88%)

REGN Regeneron
$636.37 /

-17.98 (-2.75%)

RDHL RedHill Biopharma
$2.91 /

+0.11 (+3.93%)

MRNA Moderna
$353.10 /

-15.085 (-4.10%)

MRK Merck
$74.87 /

-0.005 (-0.01%)

LULU Lululemon
$454.65 /

-9.6 (-2.07%)

JKS JinkoSolar
$52.32 /

-3.6 (-6.44%)

FB Facebook; also tag MVRS
$324.30 /

-13.525 (-4.00%)

DLTR Dollar Tree
$133.57 /

-7.89 (-5.58%)

BYND Beyond Meat
$70.33 /

-4.23 (-5.67%)

BNED Barnes & Noble Education
$7.03 /

-1.865 (-20.97%)

BIIB Biogen
$235.67 /

-0.68 (-0.29%)

AMZN Amazon.com
$3,507.58 /

-54.42 (-1.53%)

SPY SPDR S&P 500 ETF Trust
$455.84 /

-8.8 (-1.89%)

SPX S&P 500
/

+

Hot Stocks
MasterCard announces new $8B share buyback program » 16:08
11/30/21
11/30
16:08
11/30/21
16:08
MA

MasterCard

$314.10 /

-8.88 (-2.75%)

The new share repurchase…

The new share repurchase program will become effective at the completion of the company's previously announced $6B program. The company has approximately $4.4B remaining under the current program authorization.

ShowHide Related Items >><<
MA MasterCard
$314.10 /

-8.88 (-2.75%)

MA MasterCard
$314.10 /

-8.88 (-2.75%)

11/17/21 UBS
UBS assumes coverage of MasterCard with a Buy, citing increasing travel demand
11/17/21 UBS
MasterCard assumed with a Buy at UBS
11/17/21 Cowen
Amazon to stop accepting Visa cards in UK, says Cowen
11/15/21 Mizuho
MasterCard price target raised to $465 from $450 at Mizuho
MA MasterCard
$314.10 /

-8.88 (-2.75%)

MA MasterCard
$314.10 /

-8.88 (-2.75%)

MA MasterCard
$314.10 /

-8.88 (-2.75%)

MA MasterCard
$314.10 /

-8.88 (-2.75%)

Hot Stocks
MasterCard raises quarterly dividend to 49c from 44c per share » 16:07
11/30/21
11/30
16:07
11/30/21
16:07
MA

MasterCard

$314.10 /

-8.88 (-2.75%)

The cash dividend will be…

The cash dividend will be paid on February 9, 2022 to holders of record of its Class A common stock and Class B common stock as of January 7, 2022.

ShowHide Related Items >><<
MA MasterCard
$314.10 /

-8.88 (-2.75%)

MA MasterCard
$314.10 /

-8.88 (-2.75%)

11/17/21 UBS
UBS assumes coverage of MasterCard with a Buy, citing increasing travel demand
11/17/21 UBS
MasterCard assumed with a Buy at UBS
11/17/21 Cowen
Amazon to stop accepting Visa cards in UK, says Cowen
11/15/21 Mizuho
MasterCard price target raised to $465 from $450 at Mizuho
MA MasterCard
$314.10 /

-8.88 (-2.75%)

MA MasterCard
$314.10 /

-8.88 (-2.75%)

MA MasterCard
$314.10 /

-8.88 (-2.75%)

MA MasterCard
$314.10 /

-8.88 (-2.75%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.